Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Windisch

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Neurobiology of Aging|January 27, 2015
L-type calcium channel blockers and substance P induce angiogenesis of cortical vessels associated with beta-amyloid plaques in an Alzheimer mouse modelNina Daschil, Kathrin M Kniewallner, Gerald J Obermair, et al.
Journal of Molecular Neuroscience : MN|February 22, 2012
Stable mutated tau441 transfected SH-SY5Y cells as screening tool for Alzheimer's disease drug candidatesTina Löffler, Stefanie Flunkert, Nicole Taub, et al.
Journal of Molecular Neuroscience : MN|July 7, 2010
Comparison of pharmacological modulation of APP metabolism in primary chicken telencephalic neurons and in a human neuroglioma cell lineStefan Czvitkovich, Stephan Duller, Else Mathiesen, et al.
Journal of Alzheimer'S Disease : JAD|August 17, 2013
CaV1.2 calcium channel expression in reactive astrocytes is associated with the formation of amyloid-β plaques in an Alzheimer's disease mouse modelNina Daschil, Gerald J Obermair, Bernhard E Flucher, et al.
Neuro-Degenerative Diseases|June 27, 2015
Influence of Lentiviral β-Synuclein Overexpression in the Hippocampus of a Transgenic Mouse Model of Alzheimer's Disease on Amyloid Precursor Protein Metabolism and PathologyStefanie Krassnig, Cornelia Schweinzer, Nicole Taub, et al.
Journal of Neuroscience Research|March 15, 2005
Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion proteinEdward Rockenstein, Gert Schwach, Elisabeth Ingolic, et al.
BMC Neuroscience|January 11, 2013
Time course and progression of wild type α-synuclein accumulation in a transgenic mouse modelDavid Amschl, Jörg Neddens, Daniel Havas, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 24, 2009
Inhibition of acyl-coenzyme A: cholesterol acyl transferase modulates amyloid precursor protein trafficking in the early secretory pathwayHenri J Huttunen, Camilla Peach, Raja Bhattacharyya, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 24, 2007
Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood-brain barrierIngrid Kratzer, Karin Wernig, Ute Panzenboeck, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 27, 2020
Safety and pharmacokinetics of the orally available antiprionic compound PRI-002: A single and multiple ascending dose phase I studyJanine Kutzsche, Dagmar Jürgens, Antje Willuweit, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Neurobiology of Aging|January 27, 2015
L-type calcium channel blockers and substance P induce angiogenesis of cortical vessels associated with beta-amyloid plaques in an Alzheimer mouse modelNina Daschil, Kathrin M Kniewallner, Gerald J Obermair, et al.
Journal of Molecular Neuroscience : MN|February 22, 2012
Stable mutated tau441 transfected SH-SY5Y cells as screening tool for Alzheimer's disease drug candidatesTina Löffler, Stefanie Flunkert, Nicole Taub, et al.
Journal of Molecular Neuroscience : MN|July 7, 2010
Comparison of pharmacological modulation of APP metabolism in primary chicken telencephalic neurons and in a human neuroglioma cell lineStefan Czvitkovich, Stephan Duller, Else Mathiesen, et al.
Journal of Alzheimer'S Disease : JAD|August 17, 2013
CaV1.2 calcium channel expression in reactive astrocytes is associated with the formation of amyloid-β plaques in an Alzheimer's disease mouse modelNina Daschil, Gerald J Obermair, Bernhard E Flucher, et al.
Neuro-Degenerative Diseases|June 27, 2015
Influence of Lentiviral β-Synuclein Overexpression in the Hippocampus of a Transgenic Mouse Model of Alzheimer's Disease on Amyloid Precursor Protein Metabolism and PathologyStefanie Krassnig, Cornelia Schweinzer, Nicole Taub, et al.
Journal of Neuroscience Research|March 15, 2005
Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion proteinEdward Rockenstein, Gert Schwach, Elisabeth Ingolic, et al.
BMC Neuroscience|January 11, 2013
Time course and progression of wild type α-synuclein accumulation in a transgenic mouse modelDavid Amschl, Jörg Neddens, Daniel Havas, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 24, 2009
Inhibition of acyl-coenzyme A: cholesterol acyl transferase modulates amyloid precursor protein trafficking in the early secretory pathwayHenri J Huttunen, Camilla Peach, Raja Bhattacharyya, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 24, 2007
Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood-brain barrierIngrid Kratzer, Karin Wernig, Ute Panzenboeck, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 27, 2020
Safety and pharmacokinetics of the orally available antiprionic compound PRI-002: A single and multiple ascending dose phase I studyJanine Kutzsche, Dagmar Jürgens, Antje Willuweit, et al.
Pageof 6